🇺🇸 150% bolus insulin correction in United States

150% bolus insulin correction (150% bolus insulin correction) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

150% bolus insulin correction in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is 150% bolus insulin correction approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for 150% bolus insulin correction in United States?

LMC Diabetes & Endocrinology Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.